Point72 Hong Kong’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,355
Closed -$32K 1415
2022
Q3
$32K Sell
1,355
-8,761
-87% -$280K ﹤0.01% 1545
2022
Q2
$293K Buy
+10,116
New +$442K 0.01% 867
2021
Q3
Sell
-1,848
Closed -$123K 2392
2021
Q2
$123K Buy
+1,848
New +$100K ﹤0.01% 1271
2021
Q1
Sell
-392
Closed -$11K 2169
2020
Q4
$11K Buy
+392
New +$9.76K ﹤0.01% 1527
2019
Q3
Sell
-681
Closed -$6K 1305
2019
Q2
$6K Buy
+681
New +$6.79K ﹤0.01% 910
2019
Q1
Sell
-733
Closed -$7K 1254
2018
Q4
$7K Buy
+733
New +$9.84K ﹤0.01% 595

Other funds holding SGRY

Point72 Hong Kong's SGRY Position: Q4 2022 in Review

Point72 Hong Kong sold out of Surgery Partners (SGRY) in Q4 2022, closing a stake of 1,355 shares — an estimated $32K sold.

Point72 Hong Kong first reported a position in SGRY in Q4 2018 and held it in 6 quarters. The position peaked at $293K in Q2 2022. 161 funds tracked by Wall St. Rank hold SGRY as of Q4 2022.

  • Point72 Hong Kong reported no remaining Surgery Partners position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,355 Surgery Partners shares in Q4 2022, an estimated $32K.
  • Point72 Hong Kong first reported a position in Surgery Partners in Q4 2018 and held it in 6 quarters.
  • Point72 Hong Kong's Surgery Partners position peaked at $293K in Q2 2022.
  • 161 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.